Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients. [electronic resource]
Producer: 20140902Description: 957-67 p. digitalISSN:- 1532-8600
- Adamantane -- adverse effects
- Aged
- Diabetes Mellitus, Type 2 -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Double-Blind Method
- Drug Therapy, Combination -- adverse effects
- Female
- Humans
- Hyperglycemia -- prevention & control
- Hyperlipidemias -- complications
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- adverse effects
- Hypolipidemic Agents -- adverse effects
- Insulin Resistance
- Intention to Treat Analysis
- Male
- Metformin -- adverse effects
- Middle Aged
- Nitriles -- adverse effects
- Postprandial Period
- Pyrrolidines -- adverse effects
- Sulfonylurea Compounds -- adverse effects
- Vildagliptin
- Weight Gain -- drug effects
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.